檢索結果 - Gregory D. Busse

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hypera... 由 Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder 由 Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Gregory D. Busse, Fatima Chowdhry, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial

    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial 由 Jenny Downs, Peter Jacoby, Nicola Specchio, H Cross, S Amin, Nadia Bahi‐Buisson, Rajsekar R. Rajaraman, Bernhard Suter, Orrin Devinsky, A Aimetti, Gregory D. Busse, Heather E. Olson, S Demarest, T A Benke, E Pestana-Knight

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: